Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL133100 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL29757167 | 1.00 | CA1 (0.50) | — | |
| Oxalic Acid SCHEMBL9800290 | 0.94 | CA1 (0.62) | — | |
| Oxalic Acid SCHEMBL6129348 | 0.94 | CA1 (0.62) | — | |
| Oxalic Acid SCHEMBL8517751 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL6249387 | 0.94 | CA1 (0.44) | — | |
| Oxalic Acid SCHEMBL5142925 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL3585690 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL21047560 | 0.94 | CA1 (0.44) | — | |
| Oxalic Acid SCHEMBL4945936 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | disclosed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | disclosed |